Asymmetric dimethylarginine confers the communication between endothelial and smooth muscle cells and leads to VSMC migration through p38 and ERK1/2 signaling cascade

被引:20
作者
Sun, Lan [1 ,2 ]
Zhang, Tiantai [1 ,2 ]
Yu, Xin [3 ]
Xin, Wenyu [1 ,2 ]
Lan, Xi [1 ,2 ]
Zhang, Dan [1 ,2 ]
Huang, Chao [1 ,2 ]
Du, Guahua [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Natl Ctr Pharmaceut Screening, Inst Mat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] Yantai Univ, Dept Geriatr Cardiol, Yantai, Peoples R China
基金
美国国家科学基金会;
关键词
Asymmetric dimethylarginine; Oxide LDL; Vascular smooth muscle cell; Atherosclerosis; Migration; MAPK; CHOLESTEROL-FED RABBITS; ENDOGENOUS INHIBITOR; INDUCED APOPTOSIS; EXPRESSION; PROLIFERATION; PATHWAY; PLASMA; KINASE;
D O I
10.1016/j.febslet.2011.07.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Communication between endothelial and smooth muscle cells (SMCs) contributes to atherosclerosis induced by atherogenic factors, such as oxide LDL. Asymmetric dimethylarginine (ADMA), a newly found cardiovascular risk factor, accumulates in the culture medium of oxide LDL (oxLDL)-treated endothelial cells and positively correlates with atherosclerosis. This study demonstrates that ADMA mediates the communication between endothelial cells and SMCs induced by oxLDL leading to SMC migration. In addition, the present study suggests exogenous ADMA directly induces SMC migration via p38 and ERK1/2 MAPK signaling transduction way. Investigations to identify the factors regulating VSMC migration may provide novel insights into atherosclerosis and its complications. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2727 / 2734
页数:8
相关论文
共 25 条
[1]  
ALBASANZPUIG A, 2011, ATHEROSCLEROSIS 0302
[2]  
Bates DM., 1988, NONLINEAR REGRESSION, P365, DOI 10.1002/9780470316757
[3]   Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits [J].
Böger, RH ;
Bode-Böger, SM ;
Kienke, S ;
Stan, AC ;
Nafe, R ;
Frölich, JC .
ATHEROSCLEROSIS, 1998, 136 (01) :67-77
[4]   Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Sydow, K ;
Heistad, DD ;
Lentz, SR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1557-1564
[5]   The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor [J].
Böger, RH .
CARDIOVASCULAR RESEARCH, 2003, 59 (04) :824-833
[6]   Induction of MIF expression by oxidized LDL via activation of NF-κB in vascular smooth muscle cells [J].
Chen, Lihong ;
Yang, Guangrui ;
Zhang, Xiaoyan ;
Wu, Jing ;
Gu, Qing ;
Wei, Mingfen ;
Yang, Jichun ;
Zhu, Yi ;
Wang, Nanping ;
Guan, Youfei .
ATHEROSCLEROSIS, 2009, 207 (02) :428-433
[7]   The Crataegus extract WS® 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-β [J].
Fuerst, Robert ;
Zirrgiebel, Ute ;
Totzke, Frank ;
Zahler, Stefan ;
Vollmar, Angelika M. ;
Koch, Egon .
ATHEROSCLEROSIS, 2010, 211 (02) :409-417
[8]   Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells [J].
Hasegawa, Kazuhiro ;
Wakino, Shu ;
Tanaka, Toru ;
Kimoto, Masumi ;
Tatematsu, Satoru ;
Kanda, Takeshi ;
Yoshioka, Kyoko ;
Homma, Koichiro ;
Sugano, Naoki ;
Kurabayashi, Masahiko ;
Saruta, Takao ;
Hayashi, Koichi .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) :1488-1494
[9]   Methyl selenium-induced vascular endothelial apoptosis is executed by caspases and principally mediated by P38 MAPK pathway [J].
Jiang, C ;
Kim, KH ;
Wang, ZS ;
Lü, J .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2004, 49 (02) :174-183
[10]   Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension [J].
Li, Xiao-Hui ;
Peng, Jun ;
Tan, Na ;
Wu, Wei-Hua ;
Li, Ting-Ting ;
Shi, Rui-Zheng ;
Li, Yuan-Jian .
VASCULAR PHARMACOLOGY, 2010, 53 (5-6) :223-229